MedPath

Effect of oral methotrexate and oral prednisolone in Lichen planopilaris

Phase 3
Conditions
ichen planopilaris.
Lichen planopilaris
L66.1
Registration Number
IRCT20190911044742N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
28
Inclusion Criteria

Scalp involvement more than 10% ( New cases and resistant to topical therapy cases)
Localized scalp involvement (less than 10%) resistant to systemic and topical therapy

Exclusion Criteria

Pregnancy and lactation
Hemoglobin < 9 mg/ dl
Leukocyte < 4000
Platelet < 100000
Liver enzymes higher than 2 fold normal range
Positive hepatitis viral test
Diabetes
Hypothyroidism and hyperthyroidism
Severe hypertension
Heart failure
Active infection
Nephropathy
Peptic ulcer

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath